InvestorsHub Logo
Followers 19
Posts 2315
Boards Moderated 0
Alias Born 03/12/2013

Re: guardiangel post# 24020

Monday, 10/20/2014 12:40:51 AM

Monday, October 20, 2014 12:40:51 AM

Post# of 30046
Onko-Sute and AMDL/Radient are still "Doing business as usual".... Here is the link to Onko-Sure being sold in Italy on April 18, 2014. Three days after RXPC shares were voluntarily and temporarily surrendered. Our skeptics will say.."Just extra kits"... Wolf.....ahooooololoooooo

Who is the distributor in Italy?




http://www.medicinalive.com/medicina-tradizionale/oncologia/onko-sure-in-italia-cancer-test-dove-farlo-quando/



Section 1 - Registrant’s Business and Operations

Item 1.01 - Entry into Material Definitive Agreements

We filed a Current Report on Form 8-K on June 11, 2013 to disclose our entry into a 5-year license agreement between AMDL Diagnostics, Inc. (“ADI”), a division within our company, and Uni Pharma Co., Ltd. a Taipei Taiwan limited liability company (“UNI”) that provides UNI with a 5-year exclusive license (subject to automatic renewal for an additional 5 years) to RXPC’s Onko-Sure® (formerly called DR-70 cancer blood test kits (the “Tests”), procedures, analyses, data, know how, manufacturing, manufacturing processes, components, trademarks and intellectual property.

The initial 8-K and the agreement attached as Exhibit 10.1 to the initial 8-K inaccurately disclosed that UNI only has exclusive license rights in Taiwan; however, the final agreement provides UNI with exclusive rights to the license in all of the following territories: Taiwan ROC, China PRC, Hong Kong, Malaysia, Singapore, Indonesia, Thailand, Japan, India, Turkey Australia and New Zealand. We are filing this amendment to disclose same and to file the final version of the agreement as an exhibit.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.